2020 Exhibitors Search
CENYX BIOTECH
Booth no.
Stage B
| Country | Korea, South |
|---|---|
| Address | |
| Tel (Rep.) | 02-741-6110 |
| undecided | |
| Website | http://www.cenyxbiotech.com/ |
Company Introduction
Cenycbiotech inc. was established by CEO Seung-Hoon Lee, a professor of neurology at Seoul National University Hospital to introduce the world about 10 years of research achievements in the nanobio field. Our aim is to develop and commercialize a new nanozyme drug with strong antioxidant and anti-inflammatory effects for the first time in the world, and we are expanding the scope of research to various acute inflammatory diseases through various nanozyme treatments.
Promotional video
undecided
Exhibit Item
Exhibit Item Images
-
Exhibit Name : CX seriesThe CX series, a key technology at Cenyx Biotech, is a nanozyme based on CX synthetic platform technology. These nanocompounds can provide a variety of functions in nanozyme reactions, and it is being developed as the world's first nanozyme technology to be used in clinical applications.
Exhibit Description
Nanozymes are medical nanoparticles and substitutes for enzymes that maximize the activity of those enzymes in the body. Nanozymes can be designed for the type, composition and additive of nanoparticles, according to the therapeutic effects required to treat the target disease. Nanozymes can be produced most appropriately for each disease.
Co-Exhibitor or Partner’s Information
| Company Name | Country |
|---|---|
| undecided | undecided |
KYUNGYON EXHIBITION CORP.